First Sofdra prescriptions for excessive sweating condition pushes Botanix towards full commercial launch
Botanix (ASX:BOT) has reported the first prescriptions of its drug Sofdra (sofpironium)…
Botanix Pharmaceuticals Ltd (ASX:BOT)
About Botanix Pharmaceuticals Ltd
Key Information
BOT In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 17/12/2024 | Price Sensitive PS First Sofdra Prescriptions as Commercialisation Ramps Up | 2.7MB | 42K |
| 03/12/2024 | Change of Director's Interest Notice x 5 | 762.43KB | 5.9K |
| 02/12/2024 | Section 708A(5)(e) Notice | 128.44KB | 1.7K |
| 02/12/2024 | Notification regarding unquoted securities - BOT | 16.86KB | 5.0K |
| 02/12/2024 | Application for quotation of securities - BOT | 17.3KB | 493 |
| 19/11/2024 | Botanix Presentation at Bell Potter Healthcare Conference | 1.04MB | 53K |
| 14/11/2024 | Botanix Adds to Payer Coverage | 199.65KB | 62K |
| 04/11/2024 | Results of Annual General Meeting | 150.66KB | 33K |